Low circulating levels of gastrin-17 in patients with Barrett's esophagus
Open Access
- 1 January 2005
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (38) , 5988-92
Abstract
To examine whether the fasting levels of serum gastrin-17 (G-17) are lower in Barrett's esophagus (BE) patients than in non-Barrett controls. Nineteen patients with BE (presenting with a tubular segment > or =2 cm long in lower esophagus and intestinal metaplasia of incomplete type ("pecialized columnar epithelium") in endoscopic biopsies from the tubular segment below the squamocolumnar junction were collected prospectively from outpatients referred to diagnostic gastroscopy. The controls comprised 199 prospectively collected dyspeptic outpatients without BE or any endoscopically visible lesions in the upper GI tract. Fasting levels of serum G-17 (G-17fast) were assayed with an EIA test using a mAb highly specific to amidated G-17. None of the patients and controls received therapy with PPIs or other antisecretory agents. The mean and median levels of G-17fast in serum were significantly lower (P = 0.001) in BE patients than in controls. The positive likelihood ratios (LR+) of low G-17fast to predict BE in the whole study population at G-17fast levels <0.5, <1, or <1.5 pmol/L were 3.5, 3.0, and 2.8, respectively. Among patients and controls with healthy stomach mucosa, the LR+ were 5.6, 3.8, and 2.6, respectively. In the whole study population, serum G-17 was below 2 pmol/L in 15 of 19 BE patients (79%). The corresponding prevalence was 66 of 199 (33%) in controls (P<0.001). The G-17fast was 5 pmol/L or more in only one of the 19 BE patients (5%). In controls, 76 of the 199 patients (38%) had such high serum G-17fast levels (P<0.01). Serum levels of G-17fast tend to be lower in native patients with BE than in healthy controls.Keywords
This publication has 25 references indexed in Scilit:
- Gastrin-17 specific antibodies are too specific for gastrinoma diagnosis but stain G-cellsScandinavian Journal of Gastroenterology, 2005
- Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen IEuropean Journal of Gastroenterology & Hepatology, 2003
- Barrett's esophagus: prevalence in symptomatic relativesAmerican Journal of Gastroenterology, 2002
- Barrett's esophagusGastroenterology, 2002
- Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagusAlimentary Pharmacology & Therapeutics, 2002
- Columnar-lined esophagus: DefinitionsChest Surgery Clinics of North America, 2002
- Effect of Gastrin-17 on Lower Esophageal Sphincter Characteristics in ManDigestive Diseases and Sciences, 1997
- Increased Concentrations of the NH 2 -Terminal Fragment of Gastrin-17 in Acute Duodenal Ulcer and Acute GastritisScandinavian Journal of Gastroenterology, 1983
- Relation of gastric acid and pepsin secretion to serum gastrin levels in dogs given bombesin and gastrin-17American Journal of Physiology-Gastrointestinal and Liver Physiology, 1983
- THE HETEROGENEITY OF GASTRIN, WITH REFERENCE TO CONVERSION OF GASTRIN-17Clinical Endocrinology, 1976